WEX

WEX is developing a new class of non-opioid analgesics. WEX's lead product, Halneuron®, is a highly selective sodium channel blocker being developed to treat moderate-to-severe chemotherapy induced neuropathic pain, cancer pain, and other pain indications... WEX Pharmaceuticals Inc. ("WEX" or the "Company") is a private biopharmaceutical company based in Vancouver, Canada, developing a new class of non-opioid analgesics. WEX's proprietary platform and the lead product is Halneuron®. The active pharmaceutical ingredient in Halneuron is Tetrodotoxin (TTX) which is a proven sodium channel blocker known to be effective for pain relief.

Primary location: Vancouver Canada